SOURCES SOUGHT
66 -- AIM V Serum Free Medium
- Notice Date
- 5/30/2017
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
- ZIP Code
- 20892-5480
- Solicitation Number
- 17011082
- Archive Date
- 6/13/2017
- Point of Contact
- Andre M. Moody, Phone: 3014022677
- E-Mail Address
-
moodya@cc.nih.gov
(moodya@cc.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS (RFQ); NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT. This synopsis is for information and planning purposes only and is not to be construed as a commitment by the government. This is NOT a Request for Proposal, Invitation for Bid, or an announcement of a solicitation. Response to this SOURCES SOUGHT is strictly voluntary and will not affect any firms' ability to submit an offer if a solicitation is released. There is no bid package or solicitation document associated with this announcement. The purpose of this document is to identify potential sources. Any requests for a solicitation package will be disregarded. The Government does not intend to award a contract on the basis of this source sought or otherwise pay for the information solicited. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of preparing submissions in response to this sources sought and the Government's use of such information. This sources sought is being conducted to identify potential Small Manufactures/Authorized Distributors capable of producing or supplying Brand Name Supplies. SCOPE OF WORK Catalog NumberDescription Quantity T01-3621-52AIM V -Serum Free Medium360 bottles Period of Performance: The period of performance for these products is one (1) year. July 1, 2017 - June 30, 2018. Deliver 30 bottles each month to Cell Processing Section. Delivery Schedule: Deliver 30 bottles each month to Cell Processing Section. Scope of Work: This media is used to expand autologous and allogeneic Chimeric antigen Receptor (CAR) anti-Cd10 cell products that are used to treat patients with B cell malignancies. Many of these patients have already begun a series of CAR cell treatments that would be interrupted if this were not available. This media must come from the same vendor so as to ensure consistency and not introduce a new media which could be responsible for potentially altering the results and in turn, adversely affect the processing of cells and patient treatment plan. The use for the AIM V media is set forth by the investigator and is protocol specific for which there is no other known source. Objective: The Cell Processing Section (CPS) is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Cell processing procedures are tailored to each of the 30 or more different patient-care clinical research protocols supported. CPS manufactures cellular therapy products from more than 800 collections from patients or healthy donors per year. The products manufactured by the laboratory are used to treat NIH CC patients with cancer, hematological malignancies, marrow failure, genetic immune disorders, hematologic malignancies and autoimmune diseases. Cell Processing Section (CPS) uses the media for cells CD22 culture, BCMA cells culture, CAR T-cells culture to treat a number of disorders, including graft-versus-host disease (GVHD), ischemic heart disease, peripheral vascular disease, and autoimmune diseases. Many of these patients have already begun a series of cells treatments that would be interrupted if this were not available. This media must come from the same vendor so as not to affect the processing of cells and patient treatment plans. Without AIM V, CPS will be unable to culture the cells for treatment. CAPABILITY STATEMENT - Any potential Manufacturer must demonstrate the following: 1) The offeror shall submit product literature for the supplies it is proposing. Capability Statement(s) should clearly identify the following: a. Name of the Manufacturer, quantity and location where the units are produced (domestic and/or international); b. A signed statement to state, "We are the Manufacturer of the items and/or we are authorized distributors of company X"; c. Estimated Number of days, after receipt of order that is typical for delivery of such items; d. Any other relevant information that is not listed above which the Government should consider in developing its minimum specifications and finalizing its market research. 2) Provide the following business information: a. DUNS number b. Company Name c. Company Address (including point of contact, phone number and email address) d. Type/Size of company, NAICS code as validated in SAMS. Respondents will NOT be notified of the results of the evaluation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/17011082/listing.html)
- Place of Performance
- Address: National Institutes of Health, 6707 Democracy Blvd., Suite 106, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04525882-W 20170601/170530234839-1667db2f93fe86c9728a230f5547a62a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |